Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharmaceut Sun Pharmaceutical Industries Ltd. | BSE 1631.65 -2.75 (-0.17%) | NSE 1631.90 -2.30 (-0.14%) | Trade | Add

BSE Live

Jan 23, 16:01

1631.65 -2.75 (-0.17%)

Volume

AVERAGE VOLUME

5-Day

379,243

10-Day

251,315

30-Day

146,945

145,935

Prev. Close

1634.40
Open Price

1640.15

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 23, 15:57

1631.90 -2.30 (-0.14%)

Volume

AVERAGE VOLUME

5-Day

3,583,955

10-Day

2,799,315

30-Day

2,176,321

1,678,658

Prev. Close

1634.20
Open Price

1640.00

Bid Price (Qty.)
1631.90 (3)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	103.56	103.56	103.56	96.70	92.87
Total Share Capital	103.56	103.56	103.56	98.07	94.27
Reserves and Surplus	5,614.42	5,047.86	4,104.06	2,351.42	1,370.67
Total Reserves and Surplus	5,614.42	5,047.86	4,104.06	2,351.42	1,370.67
Total Shareholders Funds	5,717.98	5,151.42	4,207.62	2,449.49	1,464.94
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	79.64	1,047.76	1,727.59
Deferred Tax Liabilities [Net]	125.15	123.25	119.42	113.76	107.12
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	125.15	123.25	199.06	1,161.52	1,834.71
CURRENT LIABILITIES
Short Term Borrowings	29.49	23.60	22.88	20.39	18.23
Trade Payables	148.25	477.79	646.48	67.45	76.96
Other Current Liabilities	115.05	95.30	79.83	164.02	89.22
Short Term Provisions	342.48	342.10	262.79	7.70	122.50
Total Current Liabilities	635.27	938.79	1,011.98	259.56	306.91
Total Capital And Liabilities	6,478.40	6,213.46	5,418.66	3,870.57	3,606.56
ASSETS
NON-CURRENT ASSETS
Tangible Assets	696.06	654.80	585.58	544.90	491.80
Intangible Assets	44.46	44.46	44.46	44.39	44.39
Capital Work-In-Progress	92.15	75.95	33.43	31.91	30.80
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	832.67	775.21	663.47	621.20	566.99
Non-Current Investments	3,951.69	2,694.59	1,843.57	1,057.49	779.62
Deferred Tax Assets [Net]	9.82	5.83	6.48	4.44	2.68
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	4,794.18	3,475.63	2,513.52	1,683.13	1,349.29
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	570.14	486.74	389.63	333.38	263.41
Trade Receivables	553.29	680.03	1,055.44	310.00	256.47
Cash And Cash Equivalents	187.27	1,265.47	1,072.42	1,202.68	1,230.82
Short Term Loans And Advances	373.52	305.59	387.65	341.38	506.57
OtherCurrentAssets	0.00	0.00	0.00	0.00	0.00
Total Current Assets	1,684.22	2,737.83	2,905.14	2,187.44	2,257.27
Total Assets	6,478.40	6,213.46	5,418.66	3,870.57	3,606.56
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	184.24	85.36	72.08	107.62	39.76
CIF VALUE OF IMPORTS
Raw Materials	327.29	259.26	248.64	220.20	179.04
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	24.20	36.77	19.44	59.00	29.61
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	111.41	129.86	104.43	112.49	74.62
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	838.95	813.77	806.45	480.56	365.21
Other Earnings	11.88	14.34	88.62	1.38	39.64
BONUS DETAILS
Bonus Equity Share Capital	80.82	80.82	80.82	80.82	80.82
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	571.22	150.04	603.19	444.06	490.53
Non-Current Investments Unquoted Book Value	3,580.97	2,664.20	1,808.96	1,022.88	745.01
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--